Orally ingestible preparation of mistletoe lectins and method

Details Orally ingestible preparation of mistletoe lectins and method Orally ingestible preparation of mistletoe lectins and method

2001-11-12

2009-06-23

Leith, Patricia (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

C530S396000, C530S395000, C530S370000

Reexamination Certificate

active

07550159

ABSTRACT:
An orally ingestible preparation consisting essentially of Mistletoe lectin I (ML-I), Mistletoe lectin II (ML-II), and Mistletoe lectin III (ML-III), which specifically excludes the nausea-inducing compounds present in mistletoe extracts. The invention also provides for a method of producing said preparation, a method of using said preparation to produce pharmaceutical preparations, and a method for using said preparation in the treatment of patients suffering from cancer and auto immune diseases.

REFERENCES:
patent: 5595756 (1997-01-01), Bally et al.
patent: 4229876 (1994-03-01), None
patent: 4421895 (1996-01-01), None
Eifler, R. et al. Improved Procedures for Isolation of Mistletoe Lectins and Their Subunits: Lectin Pattern of the European Mistletoe; Lectins: Biochemcistry and Clinical Biochemistry, vol. 9, (1993) pp. 144-151.
Franz, M et al. Isolation and Quantification of Chitin-Binding Mistletoe Lectin From Mistletoe Extracts and Validation of This Method; Arzneimittelforschung, 2004; 54(4), pp. 230-239.
Kopp, J. et al. Toxicity of Mistletoe Lectins I, II , III on Normal and Malignant Cells; Lectins: Biology, Biochemistry, Clinical Biochemistr; vol. 8, (1993), pp. 41-47.
Wacker, R. et al. Complete Structure Determination of the A Chain of Mistletoe Lectin III From Viscum Album L. SSP. Album; J. Peptide Science Mar. 2004, 10 (3): 138-48.
Gura, T. Systems for Identifying New Drugs are Often Faulty; Science, vol. 278, Nov. 1997, pp. 1041-1042.
Zarkovic, et. al., “Comparison of the effects of Viscum album LEctin ML-I and Fresh Plant Extract (Isorel) on the Cell Growth in vitro and Tumorigenicity of Melanoma B16F10”, Cancer Biotherapy, V. 13, n. 2, p. 121 (1998).
Pryme et al, “The induction of gut hyperplasia by phytohaemaggluttin in the diet and limitation of tumor growth”, Histology Histopathology (1998) 13:575-583 et al.
Pryme et al, “Mistletoe lectin supplementation and reduced growth of a murine non-Hodgkin lymphoma”, Histology Histopathology (2002) 17:261-271.
Pryme et al, “A mistletoe lectin (ML-I)-containing diet reduces the viability of a murine non-Hodgkin lymphoma tumor”, Cancer Detection and Prevention, 28 (2004) 52-56.
Pryme et al, “Suppression of growth of tumor cell lines in vitro and tumours in vivo by mistletoe lectins”, Histology and Histopathology, (2006) 21:285-299.
Nielsen & Nawaz, “Mistletoe lectins in cancer thereapy”, Dissertation submitted to the Medical Faculty, Universsty of Bergen, Norway, Autumn 2002.
Winge et al, “A mistletoe tea containing lectins taken orally by humans provokes an immune response and induces an increase in the population of natural killer cells”, Submitted for publication (2007).
Hall, et al, “Assessing Mistleto Toxicity”, Annals of Emergency Medicine, Nov. 15, 1986.
Krenzelck et al, “American Mistletoe Exposures” American Journal of Emergency Medicine, Sep. 15, 1997.
Kaegi, “Unconventional Therapies for cancer: 3 Iscador” Canadian Medical Association, 5:5(158) 1998.
Stein, GM et al., “Viscotoxin-Free Aqueous Extracts from European Mistletoe (Viscum albumL.) Stimulate Activity of Human Granulocytes”, AntiCancer Research, pp. 2925-2928; 19 (1999).

Affiliated with

Also associated with

Rating

Orally ingestible preparation of mistletoe lectins and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally ingestible preparation of mistletoe lectins and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally ingestible preparation of mistletoe lectins and method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4141037